Literature DB >> 28039843

IL-3 and GM-CSF modulate functions of splenic macrophages in ENU induced leukemia.

Ashish Kumar Singha1, Bhaskar Bhattacharjee1, Bhaskar Saha2, Debasish Maiti3.   

Abstract

Leukemia is often accompanied by enhanced susceptibility to infection due to compromised B cell and T cell functions. The alterations in macrophage functions in leukemia remain less investigated. Herein, we examined macrophages for their functions and responsiveness to IL-3 and GM-CSF in ENU-induced leukemia in BALB/c mice. We observed that the macrophages from the leukemic mice had less phagocytic activity, reduced chemotactic activity in response to monocyte chemoattractant protein-1(MCP-1), and decreased expression of iNOS, GM-CSF, TLR2, TLR4, IFN-γ and TNF-α. These impaired macrophage functions in leukemic mice were significantly corrected by IL-3 and GM-CSF treatment indicating the therapeutic benefit of these two cytokines in leukemia. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemotaxis; Granulocyte macrophage-colony stimulating factor; IFN-γ; Interleukin-3; Leukemia; Monocyte-derived macrophages; Nitric oxide synthase 2; Phagocytosis; TLRs

Mesh:

Substances:

Year:  2016        PMID: 28039843     DOI: 10.1016/j.cyto.2016.12.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  Interleukin-3 plays a vital role in hyperoxic acute lung injury in mice via mediating inflammation.

Authors:  Zhijian Huang; Wei Zhang; Jian Yang; Feiyu Sun; Hongwei Zhou
Journal:  BMC Pulm Med       Date:  2018-10-30       Impact factor: 3.317

2.  N-Ethyl-n-Nitrosourea Induced Leukaemia in a Mouse Model through Upregulation of Vascular Endothelial Growth Factor and Evading Apoptosis.

Authors:  Abdullahi Aliyu; Mohd Rosly Shaari; Nurul Syahirah Ahmad Sayuti; Mohd Farhan Hanif Reduan; Shanmugavelu Sithambaram; Mustapha Mohamed Noordin; Khozirah Shaari; Hazilawati Hamzah
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.